ATHA (athira.com) Company Projected Revenue

Athira Pharma Inc - graphic logo of issuer ATHA

Athira Pharma, Inc. (ATHA) is currently reviewing its assets due to testing issues, which is leading to increased restructuring costs. The automation of molecule screening is accelerating their scientific research. The revenue forecast on the GURU.Markets chart, where the 0.00 metric reflects current dynamics, highlights the potential of this Alzheimer's therapy innovator, which restores neural connections via HGF technology.

ATHA - Athira Pharma Corp Company Future Revenue over the range 07/04/2022 - 01/12/2026

Financial and market metric breakdowns for Athira Pharma Corp (ATHA)

- current price and projected stock value:
- business market valuation indicators:
Fundamental company analysis:athira.com
Signature product of Athira

This metric determines the potential for generating future cash flows, uncovering hidden business vulnerabilities during periods of market optimism. The calculation is based on assessing the issuer's ability to scale commercial revenues through a series of sustainable highs. By analyzing the company's prospective revenue, an investor evaluates the real pace of operational expansion. For Athira Pharma, Inc. (ATHA), this reflects market demand for unique neuroregenerative drugs. The trend confirms the commercial viability of methods for combating Alzheimer's disease.

Analysis of competing companies

Company Future Sales Volume BIIB (Biogen)|NBIX (Neurocrine Biosciences, Inc.) - Company Future Revenue|Company Projected Revenue Regencell RGC|Company Projected Revenue Volume AXSM (Axsome Therapeutics Inc)|ACADIA Pharmaceuticals - Projected Sales Volume|XENE - Projected Sales Volume|VKTX: Projected Sales Volume|Company Expected Revenue SUPN (Supernus)|CPRX (Catalyst Pharmaceuticals Inc) - Projected Sales Volume|DNLI: Company Future Revenue|Company Projected Revenue harmonybiosciences.com (HRMY)|Biohaven - Company Revenue Forecast|Projected Sales Volume AMLX (amylyx.com)|Trevi Pharma (TRVI) - Company Expected Sales Volume|Praxis Corp - Projected Sales Volume|Anavex Corp (AVXL) - Company Future Sales Volume|CBLL: Projected Sales Volume|Prothena Biosciences - Company Future Revenue|ALEC (alector.com) - Projected Sales Volume|Company Revenue Forecast ANNX (Annexon Biosciences)|Company Projected Revenue Omeros Corporation (OMER)|Neurogene Corp - Company Revenue Forecast|Company Projected Revenue AC Immune S.A. ACIU|Company Future Sales Voyager Therapeutics (VYGR)|Neumora - Projected Sales Volume|Company Expected Revenue SCLX|Tevogen Bio Inc. (TVGN) - Company Projected Revenue|Company Revenue Forecast ACOG|CGTX (cogrx.com) - Projected Sales Volume|Company Future Sales Volume inhibikase.com (IKT)|Company Projected Revenue Cassava Sciences Inc (SAVA)|Company Future Sales Assertio|Projected Sales Volume COYA (Coya Therapeutics, Inc.)|Company Projected Revenue Volume VTGN (VistaGen Therapeutics Inc)|OVID: Company Future Sales Volume|ABOS: Company Projected Revenue|CervoMed (CRVO) - Company Projected Revenue|Company Expected Sales Volume Alterity Therapeutics Ltd (ATHE)|CLNN (Clene) - Projected Sales Volume|Company Revenue Forecast PEPG (PepGen)|Company Future Sales Volume JUNS (Jupiter Neurosciences, Inc.)|Projected Sales Volume relmada.com (RLMD)|Company Projected Revenue Annovis Bio Corp ANVS|GRCE: Company Revenue Forecast|AIFF - Company Projected Revenue|KLTO (anewmeds.com) - Company Revenue Forecast|NRSN (NeuroSense Therapeutics Ltd.) - Company Future Sales Volume|revivapharma.com - Company Future Revenue|MTVA (metaviatx.com) - Projected Sales Volume|NRXS: Company Future Revenue|Projected Sales Volume HSDT|PASG - Company Expected Sales Volume|Projected Sales Volume NEUP (Neuphoria Therapeutics)|NERV: Company Revenue Forecast|ADXN: Company Future Sales Volume|Company Expected Sales Volume Alzamend Neuro|Cyclerion Therapeutics Inc. (CYCN) - Company Projected Revenue|Company Expected Sales Volume Protagenic Therapeutics (PTIX)|KTTA (pasitheaclinics.com) - Projected Sales Volume|Company Future Sales Volume Cortigent (CRGT)|Projected Sales Volume ATXI|BCLI - Company Expected Sales Volume|Projected Sales Volume CARA (Cara Therapeutics, Inc)|Chromocell Therapeutics Corporation (CHRO) - Company Expected Sales Volume|ELYM - Company Projected Revenue|Company Sales Forecast intracellulartherapies.com (ITCI)|Longboard (LBPH) - Company Projected Revenue|Marinus Pharmaceuticals Inc - Company Future Revenue|Company Future Sales Volume NKGN|NeuroBo - Company Expected Revenue|Company Projected Revenue Sage Therapeutics, Inc (SAGE)|Company Future Sales Volume Synaptogenix SNPX|Trevena, Inc. - Company Future Sales Volume|VIGL: Company Revenue Forecast|WENA: Company Future Sales Volume|Company Expected Sales Volume Cerevel Therapeutics